CA2650592A1 - Compositions for the treatment and prevention of eyelid swelling - Google Patents

Compositions for the treatment and prevention of eyelid swelling Download PDF

Info

Publication number
CA2650592A1
CA2650592A1 CA002650592A CA2650592A CA2650592A1 CA 2650592 A1 CA2650592 A1 CA 2650592A1 CA 002650592 A CA002650592 A CA 002650592A CA 2650592 A CA2650592 A CA 2650592A CA 2650592 A1 CA2650592 A1 CA 2650592A1
Authority
CA
Canada
Prior art keywords
active agent
effective amount
composition
group
vasoconstrictor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002650592A
Other languages
English (en)
French (fr)
Inventor
Matthew Jonathan Chapin
Mark Barry Abelson
Akimitsu Makino
Keith Jeffrey Lane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aciex Therapeutics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2650592A1 publication Critical patent/CA2650592A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA002650592A 2006-04-26 2007-04-26 Compositions for the treatment and prevention of eyelid swelling Abandoned CA2650592A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US79498306P 2006-04-26 2006-04-26
US60/794,983 2006-04-26
US84547906P 2006-09-18 2006-09-18
US60/845,479 2006-09-18
PCT/US2007/010177 WO2007127333A2 (en) 2006-04-26 2007-04-26 Compositions for the treatment and prevention of eyelid swelling

Publications (1)

Publication Number Publication Date
CA2650592A1 true CA2650592A1 (en) 2007-11-08

Family

ID=38656195

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002650592A Abandoned CA2650592A1 (en) 2006-04-26 2007-04-26 Compositions for the treatment and prevention of eyelid swelling

Country Status (7)

Country Link
US (3) US8685439B2 (enExample)
EP (1) EP2015733A2 (enExample)
JP (1) JP2009535342A (enExample)
AU (1) AU2007243334A1 (enExample)
CA (1) CA2650592A1 (enExample)
MX (1) MX2008013783A (enExample)
WO (1) WO2007127333A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8685439B2 (en) 2006-04-26 2014-04-01 Aciex Therapeutics, Inc. Method for the treatment and prevention of eyelid swelling
MX2010005012A (es) * 2007-11-08 2010-06-23 Aciex Therapeutics Inc Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
RU2600863C2 (ru) * 2007-12-10 2016-10-27 Сентисс Фарма Прайвит Лимитед Офтальмическая композиция, включающая фенилэфрин
US8778999B2 (en) 2009-03-05 2014-07-15 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic compositions
CA3239245A1 (en) 2009-08-26 2011-03-10 Mary Kay Inc. Topical skin care formulations comprising plant extracts
US20120225918A1 (en) * 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
CA2850964C (en) 2011-10-05 2021-02-02 Jennifer L. Sanders Methods and compositions for treating foot or hand pain
US20150044136A1 (en) * 2013-08-12 2015-02-12 George H. Scherr Ophthalmological treatment for michobial infections
US9874379B2 (en) * 2014-07-09 2018-01-23 Hamilton Sundstrand Corporation Expendable driven heat pump cycles
US9820954B2 (en) 2015-08-19 2017-11-21 Jenivision Inc. Quantitative peri-orbital application of ophthalmology drugs
CN115006537A (zh) * 2016-01-26 2022-09-06 利维申制药有限公司 α-肾上腺素能药剂的组合物和用途
JP2021532079A (ja) * 2018-07-12 2021-11-25 オキュソフト インコーポレイテッドOCuSOFT, Inc. 目の抗アレルギ用組成物および眼瞼洗浄ワイプ
US11077150B2 (en) * 2018-10-09 2021-08-03 Massoumeh Kharazmi Methods and compositions for treatment of eye conditions
US10814001B1 (en) 2019-05-06 2020-10-27 Rvl Pharmaceuticals, Inc. Oxymetazoline compositions
US20230012731A1 (en) * 2019-11-26 2023-01-19 Standard Of Care Corporation Hyaluronidase compositions and methods of using same to treat peri-orbital hollowness and tear through deformities
BR112022026911A2 (pt) * 2020-09-11 2023-03-28 Intratus Nevada Inc Composições e métodos para tratar presbiopia, hipermetropia, astigmatismo, diminuição da estereopsia e diminuição da sensibilidade ao contraste
AU2023352919A1 (en) 2022-09-29 2025-03-13 Adora Life Science, Inc. Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2618428A (en) 1947-01-27 1952-11-18 John K M Harrison Shock resistant container
JPS6056684B2 (ja) 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4407792A (en) 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
LU83173A1 (fr) 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4454151A (en) 1982-03-22 1984-06-12 Syntex (U.S.A.) Inc. Use of pyrrolo pyrroles in treatment of ophthalmic diseases
JPH0830004B2 (ja) 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド 生物接着性組成物およびそれにより治療する方法
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US4960799A (en) 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
IT1248014B (it) 1991-06-07 1995-01-05 Inverni Della Beffa Spa Preparazioni oftalmiche a rilascio protratto
AU684115B2 (en) 1993-12-27 1997-12-04 Mitsubishi Chemical Corporation Ophthalmic suspension containing diflupredonate
JP3781792B2 (ja) * 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
US5811446A (en) 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US6274626B1 (en) 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
AU781964B2 (en) * 1999-06-08 2005-06-23 Naturveda Non-solid composition for local application
CZ295595B6 (cs) * 1999-06-22 2005-08-17 Boehringer Ingelheim International Gmbh Stálý roztok xylometazolinu a oxymetazolinu
JP2001187728A (ja) 1999-12-28 2001-07-10 Lion Corp 眼科用組成物
DE10000612A1 (de) 2000-01-10 2001-07-19 Min Becker Flüssigkeitspräparate für Augen- und Nasen-Tropfen bzw. Nasenspray ohne Konservierungsmittel
KR100784653B1 (ko) * 2000-01-26 2007-12-12 교린 세이야꾸 가부시키 가이샤 점안제
US6572849B2 (en) * 2000-09-20 2003-06-03 Lee Shahinian, Jr. Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications
JP2002308775A (ja) 2001-04-06 2002-10-23 Rohto Pharmaceut Co Ltd 外用組成物
US6806364B2 (en) 2002-07-29 2004-10-19 Ast Products, Inc. Ophthalmic compositions
JP2004123729A (ja) * 2002-09-09 2004-04-22 Santen Pharmaceut Co Ltd ラタノプロストを有効成分とする澄明な点眼液
AU2003272517A1 (en) * 2002-09-13 2004-04-30 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20050059639A1 (en) * 2003-09-11 2005-03-17 Wei Edward T. Ophthalmic compositions and method for treating eye discomfort and pain
US7288263B2 (en) 2004-09-13 2007-10-30 Evera Laboratories, Llc Compositions and methods for treatment of skin discoloration
PL2486942T3 (pl) 2004-11-24 2019-05-31 Meda Pharmaceuticals Inc Kompozycje zawierające azelastynę oraz sposoby ich stosowania
JP2006232792A (ja) 2005-02-21 2006-09-07 Aile De Beaute:Kk 肌老化改善化粧料
SG170044A1 (en) 2006-03-31 2011-04-29 Vistakon Pharmaceuticals Llc Ocular allergy treatments
US8685439B2 (en) * 2006-04-26 2014-04-01 Aciex Therapeutics, Inc. Method for the treatment and prevention of eyelid swelling

Also Published As

Publication number Publication date
AU2007243334A1 (en) 2007-11-08
WO2007127333A2 (en) 2007-11-08
JP2009535342A (ja) 2009-10-01
US20120021072A1 (en) 2012-01-26
US8685439B2 (en) 2014-04-01
US20070264318A1 (en) 2007-11-15
WO2007127333A3 (en) 2008-08-07
US20140161903A1 (en) 2014-06-12
EP2015733A2 (en) 2009-01-21
MX2008013783A (es) 2009-02-05

Similar Documents

Publication Publication Date Title
US8685439B2 (en) Method for the treatment and prevention of eyelid swelling
US20210177807A1 (en) Compositions for the treatment and prevention of eyelid swelling
AU2008325214A1 (en) Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor
US20070254841A1 (en) Formulations and methods for treating dry eye
US20070297981A1 (en) Formulations and methods for treating dry eye
US20090010850A1 (en) Formulations and methods for treating dry eye
US20250127762A1 (en) Isoxazoline parasiticide formulations and methods for treating blepharitis
US20080039398A1 (en) Formulations and methods for treating dry eye
CA2764477A1 (en) Ophthalmic formulations, methods of manufacture, and methods of using same
US20080119448A1 (en) Methods of treating an ocular allergy with low dose dexamethasone
US20050239745A1 (en) Novel topical ophthalmic formulations
US20070166402A1 (en) Compositions, methods and kits for removing debris from an ocular area
CN101460152A (zh) 治疗以及预防眼皮肿胀的组合物
AU2019230220B2 (en) Methods of use and pharmaceutical compositions of a selective Syk inhibitor

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20130426